323 related articles for article (PubMed ID: 27295203)
1. The safety and efficacy of levetiracetam versus phenytoin for seizure prophylaxis after traumatic brain injury: A systematic review and meta-analysis.
Xu JC; Shen J; Shao WZ; Tang LJ; Sun YZ; Zhai XF; Qi L; Li J; Zheng JY
Brain Inj; 2016; 30(9):1054-61. PubMed ID: 27295203
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of Levetiracetam versus phenytoin in preventing seizure in traumatic brain injury patients: A systematic review and meta-analysis.
Karamian A; Farzaneh H; Taheri M; Seifi A
Clin Neurol Neurosurg; 2024 May; 240():108251. PubMed ID: 38569246
[TBL] [Abstract][Full Text] [Related]
3. Levetiracetam Versus Phenytoin for Seizure Prophylaxis Following Traumatic Brain Injury: A Systematic Review and Meta-Analysis.
Yang Y; Zheng F; Xu X; Wang X
CNS Drugs; 2016 Aug; 30(8):677-88. PubMed ID: 27395404
[TBL] [Abstract][Full Text] [Related]
4. [Comparisons of efficacy and safety of levetiracetam versus phenytoin for seizure prophylaxis in patients with brain injury: a meta analysis].
Li JN; Chen YM
Zhonghua Yi Xue Za Zhi; 2016 Oct; 96(39):3170-3177. PubMed ID: 27852418
[No Abstract] [Full Text] [Related]
5. Prospective, randomized, single-blinded comparative trial of intravenous levetiracetam versus phenytoin for seizure prophylaxis.
Szaflarski JP; Sangha KS; Lindsell CJ; Shutter LA
Neurocrit Care; 2010 Apr; 12(2):165-72. PubMed ID: 19898966
[TBL] [Abstract][Full Text] [Related]
6. Levetiracetam versus phenytoin for seizure prophylaxis during and early after craniotomy for brain tumours: a phase II prospective, randomised study.
Iuchi T; Kuwabara K; Matsumoto M; Kawasaki K; Hasegawa Y; Sakaida T
J Neurol Neurosurg Psychiatry; 2015 Oct; 86(10):1158-62. PubMed ID: 25511789
[TBL] [Abstract][Full Text] [Related]
7. Changing trends in the use of seizure prophylaxis after traumatic brain injury: a shift from phenytoin to levetiracetam.
Kruer RM; Harris LH; Goodwin H; Kornbluth J; Thomas KP; Slater LA; Haut ER
J Crit Care; 2013 Oct; 28(5):883.e9-13. PubMed ID: 23566730
[TBL] [Abstract][Full Text] [Related]
8. Long-term comparison of GOS-E scores in patients treated with phenytoin or levetiracetam for posttraumatic seizure prophylaxis after traumatic brain injury.
Gabriel WM; Rowe AS
Ann Pharmacother; 2014 Nov; 48(11):1440-4. PubMed ID: 25169249
[TBL] [Abstract][Full Text] [Related]
9. Tolerability, safety, and side effects of levetiracetam versus phenytoin in intravenous and total prophylactic regimen among craniotomy patients: a prospective randomized study.
Fuller KL; Wang YY; Cook MJ; Murphy MA; D'Souza WJ
Epilepsia; 2013 Jan; 54(1):45-57. PubMed ID: 22738092
[TBL] [Abstract][Full Text] [Related]
10. Early and Late Posttraumatic Epilepsy in the Setting of Traumatic Brain Injury: A Meta-analysis and Review of Antiepileptic Management.
Wilson CD; Burks JD; Rodgers RB; Evans RM; Bakare AA; Safavi-Abbasi S
World Neurosurg; 2018 Feb; 110():e901-e906. PubMed ID: 29196247
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of levetiracetam compared with phenytoin in prevention of seizures in brain injured patients: A meta-analysis.
Zhao L; Wu YP; Qi JL; Liu YQ; Zhang K; Li WL
Medicine (Baltimore); 2018 Nov; 97(48):e13247. PubMed ID: 30508910
[TBL] [Abstract][Full Text] [Related]
12. A cost-minimization analysis of phenytoin versus levetiracetam for early seizure pharmacoprophylaxis after traumatic brain injury.
Pieracci FM; Moore EE; Beauchamp K; Tebockhorst S; Barnett CC; Bensard DD; Burlew CC; Biffl WL; Stoval RT; Johnson JL
J Trauma Acute Care Surg; 2012 Jan; 72(1):276-81. PubMed ID: 22310136
[TBL] [Abstract][Full Text] [Related]
13. Should Levetiracetam or Phenytoin Be Used for Posttraumatic Seizure Prophylaxis? A Systematic Review of the Literature and Meta-analysis.
Khan NR; VanLandingham MA; Fierst TM; Hymel C; Hoes K; Evans LT; Mayer R; Barker F; Klimo P
Neurosurgery; 2016 Dec; 79(6):775-782. PubMed ID: 27749510
[TBL] [Abstract][Full Text] [Related]
14. Levetiracetam Prophylaxis for Post-traumatic Brain Injury Seizures is Ineffective: A Propensity Score Analysis.
Zangbar B; Khalil M; Gruessner A; Joseph B; Friese R; Kulvatunyou N; Wynne J; Latifi R; Rhee P; O'Keeffe T
World J Surg; 2016 Nov; 40(11):2667-2672. PubMed ID: 27307089
[TBL] [Abstract][Full Text] [Related]
15. A systematic review of levetiracetam versus phenytoin in the prevention of late post-traumatic seizures and survey of UK neurosurgical prescribing practice of antiepileptic medication in acute traumatic brain injury.
Bakr A; Belli A
Br J Neurosurg; 2018 Jun; 32(3):237-244. PubMed ID: 29688078
[TBL] [Abstract][Full Text] [Related]
16. Guidelines for Seizure Prophylaxis in Adults Hospitalized with Moderate-Severe Traumatic Brain Injury: A Clinical Practice Guideline for Health Care Professionals from the Neurocritical Care Society.
Frontera JA; Gilmore EJ; Johnson EL; Olson D; Rayi A; Tesoro E; Ullman J; Yuan Y; Zafar SF; Rowe S
Neurocrit Care; 2024 Jun; 40(3):819-844. PubMed ID: 38316735
[TBL] [Abstract][Full Text] [Related]
17. Levetiracetam versus (fos)phenytoin for seizure prophylaxis in pediatric patients with intracranial hemorrhage.
Bansal S; Blalock D; Kebede T; Dean NP; Carpenter JL
J Neurosurg Pediatr; 2014 Feb; 13(2):209-15. PubMed ID: 24286154
[TBL] [Abstract][Full Text] [Related]
18. Safety and feasibility of switching from phenytoin to levetiracetam monotherapy for glioma-related seizure control following craniotomy: a randomized phase II pilot study.
Lim DA; Tarapore P; Chang E; Burt M; Chakalian L; Barbaro N; Chang S; Lamborn KR; McDermott MW
J Neurooncol; 2009 Jul; 93(3):349-54. PubMed ID: 19169651
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of prophylactic levetiracetam in supratentorial brain tumour surgery: a systematic review and meta-analysis.
Pourzitaki C; Tsaousi G; Apostolidou E; Karakoulas K; Kouvelas D; Amaniti E
Br J Clin Pharmacol; 2016 Jul; 82(1):315-25. PubMed ID: 26945547
[TBL] [Abstract][Full Text] [Related]
20. Levetiracetam versus phenytoin for seizure prophylaxis in brain injured patients: a systematic review and meta-analysis.
Chaari A; Mohamed AS; Abdelhakim K; Kauts V; Casey WF
Int J Clin Pharm; 2017 Oct; 39(5):998-1003. PubMed ID: 28780739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
